跳至主要内容
临床试验/NCT05918380
NCT05918380进行中(未招募)不适用

ACHIEVE GREATER: Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region

University Hospitals Cleveland Medical Center2 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2022年8月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
500
试验地点
2
主要终点
Triple Goal

研究概览

简要总结

This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities and downstream Black-White lifespan inequality in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center will involve three separate but related projects that aim to mitigate health disparities in risk factor control for three chronic conditions, hypertension (HTN, Project 1), heart failure (HF, Project 2) and coronary heart disease (CHD, Project 3), which drive downstream lifespan inequality. All three projects will involve the use of Community Health Workers (CHWs) to deliver an evidence-based practice intervention program called PAL2. All three projects will also utilize the PAL2 Implementation Intervention (PAL2-II), which is a set of structured training and evaluation strategies designed to optimize CHW competence and adherence (i.e., fidelity) to the PAL2 intervention program. The present study is Project 3 of the ACHIEVE GREATER Center.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 40 to 75 years of age
  • Self-identified as Black or African American
  • Residence in the Cleveland Metro Area
  • Must have at least two of the following risk factors identified at a UH health fair screenings, with one risk factor being with SBP, A1c, or LDL:
  • BMI≥30 mg/dL
  • History of smoking
  • Elevated blood pressure defined as SBP>140 or DBP>80 mmHg
  • Able to complete a coronary artery calcium score test (CAC)
  • Willing and able to consent
  • Willing to have a UH provider and UH care
  • Currently insured for standard of care procedures

排除标准

  • Established documented cardiovascular disease (coronary artery disease, peripheral artery disease, myocardial infarction, stroke).
  • Systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 110 mmHg
  • Lung disease requiring supplemental oxygen therapy
  • Individuals receiving treatment for cancer related disease
  • Pregnant or nursing mothers

研究组 & 干预措施

Low CVD risk

Other

PAL2

干预措施: PAL2 (Behavioral)

High CVD risk

Other

Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA)

干预措施: CINEMA (Other)

结局指标

主要结局

Triple Goal

时间窗: 12 months

Percent reaching triple goal of BP \<130/80 mm Hg, HbA1c\<5.7% and LDL-C \<130 mg/dl (\<100 if high-risk)

次要结局

  • Change in blood pressure(baseline, 12 months)
  • Change in HbA1c as measured by blood work(baseline, 12 months)
  • Change in weight(baseline, 12 months)
  • Change in LDL-C as measured by blood work(baseline, 12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sanjay Rajagopalan

Chief, Cardiovascular Medicine, Chief Academic and Scientific Officer

University Hospitals Cleveland Medical Center

研究点 (2)

Loading locations...

相似试验